Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Molecular Biosciences|August 8, 2020
Current State of Target Treatment in BRAF Mutated MelanomaEnrica Teresa Tanda, Irene Vanni, Andrea Boutros, et al.
Frontiers in Molecular Biosciences|August 28, 2020
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical ImplicationsIrene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, et al.
Histochemistry and Cell Biology|January 4, 2019
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalinLuca Mastracci, Alessandro Gambella, Alberto Bragoni, et al.
Diagnostic Microbiology and Infectious Disease|January 22, 2011
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typingElisabetta Ugolotti, Roberto Bandettini, Anna Marchese, et al.
Expert Opinion on Pharmacotherapy|November 15, 2016
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancerCarlo Genova, Erika Rijavec, Federica Biello, et al.
Frontiers in Oncology|September 20, 2014
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch SystemAnna Truini, Angela Alama, Maria Giovanna Dal Bello, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 4, 2012
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patientsFabio Benzi, Irene Vanni, Giulia Cassina, et al.
Expert Opinion on Pharmacotherapy|July 18, 2014
Efficacy of motesanib diphosphate in non-small-cell lung cancerErika Rijavec, Carlo Genova, Giulia Barletta, et al.
Microrna (Shariqah, United Arab Emirates)|January 29, 2016
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural MesotheliomaAnna Truini, Simona Coco, Carlo Genova, et al.
Expert Opinion on Investigational Drugs|April 8, 2017
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancerErika Rijavec, Carlo Genova, Giulia Barletta, et al.
Pageof 5